When cerebral vasospasm after subarachnoid hemorrhage begins and ends? Definition of vasospasm using angiography

Shigeki Ono, Keisuke Onoda, Koji Tokunaga, Kenji Sugiu, Isao Date

Research output: Contribution to journalArticle

Abstract

Cerebral vasospasm (VS) after subarachnoid hemorrhage (SAH) is one of the fatal strokes causing severe brain ischemia. So far, many types of treatments for VS have been applied, such as triple H therapy, clot fibrinolysis, spinal drainage, endovascular treatment, or administration of vasodilatory agents, but its pathophysiology has been still unknown, and absolute therapeutic strategies have not been established yet. One of the reasons why the strategies of VS treatment has not been confirmed is that clear definition of VS has not given until now. For instance, there are many cases which have no symptoms while these patients have obvious angiographic VS, or it is difficult to distinguish between real VS symptoms and neurological deterioration due to fever, abnormal blood levels of electrolytes, primary brain damages from SAH. Therefore, incidence of VS and the timing of its treatment are sometimes different among each facility. From 2000, we define VS as angiographic VS in our institute. When symptomatic VS is suspected clinically, emergency angiography is immediately performed and confirm VS. And then if necessary, endovascular therapy is given. Even if there are no VS symptoms during spasm periods, we routinely perform angiography on around day 7 as shown in the following protocol (see table). Under this protocol, angiographic VS was seen in 59.7% of the 57 patients, while, symptomatic VS was seen in 37.1%. In this study, we discuss the advantages of this definition of VS by angiography. Table: A. Treatment after surgery 1) Drains(always inserted) Ventricular drainage (VD) + cisternal (CD) or lumber drainage (LD) 2) Fibrinolysis UK 30,000IU/day, injected through VD Repeated if necessary by Day 4 3) General management(under strict control) Normo-hypertension, normovolemia (≧120mmHg, CVP≒8-10) Hct(≦9.0mg/dl), ICP(≧20mmH2O),and electrolytes(≧130meq/L) Ozagrel Na (i.v.) Fasudil (i.v.) 4) Intravascular treatment (if severe angiographic VS was detected.) Fasudil (i.a.) Percutaneous transluminal angioplasty (PTA) B. Detection of VS 1) TCD monitor 2) Neurological changes 3) Angiography When TCD or neurological changes are detected On day 7 (routine exam.) 4) INVOS5100R(Somanetics, USA): 2005∼ Near infrared spectroscopy, measuring rSO2.

Original languageEnglish
JournalJournal of Cerebral Blood Flow and Metabolism
Volume27
Issue numberSUPPL. 1
Publication statusPublished - Nov 13 2007

Fingerprint

Intracranial Vasospasm
Subarachnoid Hemorrhage
Angiography
Drainage
Therapeutics
Fibrinolysis
Electrolytes
Near-Infrared Spectroscopy
Spasm
Brain Ischemia
Angioplasty
Emergencies
Fever
Stroke
Hypertension

ASJC Scopus subject areas

  • Endocrinology
  • Neuroscience(all)
  • Endocrinology, Diabetes and Metabolism

Cite this

When cerebral vasospasm after subarachnoid hemorrhage begins and ends? Definition of vasospasm using angiography. / Ono, Shigeki; Onoda, Keisuke; Tokunaga, Koji; Sugiu, Kenji; Date, Isao.

In: Journal of Cerebral Blood Flow and Metabolism, Vol. 27, No. SUPPL. 1, 13.11.2007.

Research output: Contribution to journalArticle

@article{6e964ab08f7645379664c468c21d5cee,
title = "When cerebral vasospasm after subarachnoid hemorrhage begins and ends?: Definition of vasospasm using angiography",
abstract = "Cerebral vasospasm (VS) after subarachnoid hemorrhage (SAH) is one of the fatal strokes causing severe brain ischemia. So far, many types of treatments for VS have been applied, such as triple H therapy, clot fibrinolysis, spinal drainage, endovascular treatment, or administration of vasodilatory agents, but its pathophysiology has been still unknown, and absolute therapeutic strategies have not been established yet. One of the reasons why the strategies of VS treatment has not been confirmed is that clear definition of VS has not given until now. For instance, there are many cases which have no symptoms while these patients have obvious angiographic VS, or it is difficult to distinguish between real VS symptoms and neurological deterioration due to fever, abnormal blood levels of electrolytes, primary brain damages from SAH. Therefore, incidence of VS and the timing of its treatment are sometimes different among each facility. From 2000, we define VS as angiographic VS in our institute. When symptomatic VS is suspected clinically, emergency angiography is immediately performed and confirm VS. And then if necessary, endovascular therapy is given. Even if there are no VS symptoms during spasm periods, we routinely perform angiography on around day 7 as shown in the following protocol (see table). Under this protocol, angiographic VS was seen in 59.7{\%} of the 57 patients, while, symptomatic VS was seen in 37.1{\%}. In this study, we discuss the advantages of this definition of VS by angiography. Table: A. Treatment after surgery 1) Drains(always inserted) Ventricular drainage (VD) + cisternal (CD) or lumber drainage (LD) 2) Fibrinolysis UK 30,000IU/day, injected through VD Repeated if necessary by Day 4 3) General management(under strict control) Normo-hypertension, normovolemia (≧120mmHg, CVP≒8-10) Hct(≦9.0mg/dl), ICP(≧20mmH2O),and electrolytes(≧130meq/L) Ozagrel Na (i.v.) Fasudil (i.v.) 4) Intravascular treatment (if severe angiographic VS was detected.) Fasudil (i.a.) Percutaneous transluminal angioplasty (PTA) B. Detection of VS 1) TCD monitor 2) Neurological changes 3) Angiography When TCD or neurological changes are detected On day 7 (routine exam.) 4) INVOS5100R(Somanetics, USA): 2005∼ Near infrared spectroscopy, measuring rSO2.",
author = "Shigeki Ono and Keisuke Onoda and Koji Tokunaga and Kenji Sugiu and Isao Date",
year = "2007",
month = "11",
day = "13",
language = "English",
volume = "27",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
publisher = "Nature Publishing Group",
number = "SUPPL. 1",

}

TY - JOUR

T1 - When cerebral vasospasm after subarachnoid hemorrhage begins and ends?

T2 - Definition of vasospasm using angiography

AU - Ono, Shigeki

AU - Onoda, Keisuke

AU - Tokunaga, Koji

AU - Sugiu, Kenji

AU - Date, Isao

PY - 2007/11/13

Y1 - 2007/11/13

N2 - Cerebral vasospasm (VS) after subarachnoid hemorrhage (SAH) is one of the fatal strokes causing severe brain ischemia. So far, many types of treatments for VS have been applied, such as triple H therapy, clot fibrinolysis, spinal drainage, endovascular treatment, or administration of vasodilatory agents, but its pathophysiology has been still unknown, and absolute therapeutic strategies have not been established yet. One of the reasons why the strategies of VS treatment has not been confirmed is that clear definition of VS has not given until now. For instance, there are many cases which have no symptoms while these patients have obvious angiographic VS, or it is difficult to distinguish between real VS symptoms and neurological deterioration due to fever, abnormal blood levels of electrolytes, primary brain damages from SAH. Therefore, incidence of VS and the timing of its treatment are sometimes different among each facility. From 2000, we define VS as angiographic VS in our institute. When symptomatic VS is suspected clinically, emergency angiography is immediately performed and confirm VS. And then if necessary, endovascular therapy is given. Even if there are no VS symptoms during spasm periods, we routinely perform angiography on around day 7 as shown in the following protocol (see table). Under this protocol, angiographic VS was seen in 59.7% of the 57 patients, while, symptomatic VS was seen in 37.1%. In this study, we discuss the advantages of this definition of VS by angiography. Table: A. Treatment after surgery 1) Drains(always inserted) Ventricular drainage (VD) + cisternal (CD) or lumber drainage (LD) 2) Fibrinolysis UK 30,000IU/day, injected through VD Repeated if necessary by Day 4 3) General management(under strict control) Normo-hypertension, normovolemia (≧120mmHg, CVP≒8-10) Hct(≦9.0mg/dl), ICP(≧20mmH2O),and electrolytes(≧130meq/L) Ozagrel Na (i.v.) Fasudil (i.v.) 4) Intravascular treatment (if severe angiographic VS was detected.) Fasudil (i.a.) Percutaneous transluminal angioplasty (PTA) B. Detection of VS 1) TCD monitor 2) Neurological changes 3) Angiography When TCD or neurological changes are detected On day 7 (routine exam.) 4) INVOS5100R(Somanetics, USA): 2005∼ Near infrared spectroscopy, measuring rSO2.

AB - Cerebral vasospasm (VS) after subarachnoid hemorrhage (SAH) is one of the fatal strokes causing severe brain ischemia. So far, many types of treatments for VS have been applied, such as triple H therapy, clot fibrinolysis, spinal drainage, endovascular treatment, or administration of vasodilatory agents, but its pathophysiology has been still unknown, and absolute therapeutic strategies have not been established yet. One of the reasons why the strategies of VS treatment has not been confirmed is that clear definition of VS has not given until now. For instance, there are many cases which have no symptoms while these patients have obvious angiographic VS, or it is difficult to distinguish between real VS symptoms and neurological deterioration due to fever, abnormal blood levels of electrolytes, primary brain damages from SAH. Therefore, incidence of VS and the timing of its treatment are sometimes different among each facility. From 2000, we define VS as angiographic VS in our institute. When symptomatic VS is suspected clinically, emergency angiography is immediately performed and confirm VS. And then if necessary, endovascular therapy is given. Even if there are no VS symptoms during spasm periods, we routinely perform angiography on around day 7 as shown in the following protocol (see table). Under this protocol, angiographic VS was seen in 59.7% of the 57 patients, while, symptomatic VS was seen in 37.1%. In this study, we discuss the advantages of this definition of VS by angiography. Table: A. Treatment after surgery 1) Drains(always inserted) Ventricular drainage (VD) + cisternal (CD) or lumber drainage (LD) 2) Fibrinolysis UK 30,000IU/day, injected through VD Repeated if necessary by Day 4 3) General management(under strict control) Normo-hypertension, normovolemia (≧120mmHg, CVP≒8-10) Hct(≦9.0mg/dl), ICP(≧20mmH2O),and electrolytes(≧130meq/L) Ozagrel Na (i.v.) Fasudil (i.v.) 4) Intravascular treatment (if severe angiographic VS was detected.) Fasudil (i.a.) Percutaneous transluminal angioplasty (PTA) B. Detection of VS 1) TCD monitor 2) Neurological changes 3) Angiography When TCD or neurological changes are detected On day 7 (routine exam.) 4) INVOS5100R(Somanetics, USA): 2005∼ Near infrared spectroscopy, measuring rSO2.

UR - http://www.scopus.com/inward/record.url?scp=36348958976&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36348958976&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:36348958976

VL - 27

JO - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

IS - SUPPL. 1

ER -